LIN9 regulation of NEK2 underlies taxol resistance in triple-negative breast cancer

被引：0
|
作者：
Shively, Melyssa S. [1 ]
Keri, Ruth A. [1 ]
机构：
[1] Case Western Reserve Univ, Cleveland, OH 44106 USA
来源：
CANCER RESEARCH | 2019年 / 79卷 / 13期
关键词：
D O I：
10.1158/1538-7445.SABCS18-2097
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2097
引用
收藏
页数：2
相关论文
共 50 条
  • [1] LIN9 regulation of NEK2 underlies taxol resistance in triple-negative breast cancer
    Shively, M. S.
    Gayle, S. S.
    Sahni, J. M.
    Keri, R. A.
    CANCER RESEARCH, 2019, 79 (04)
  • [2] Mitotic Vulnerability in Triple-Negative Breast Cancer Associated with LIN9 Is Targetable with BET Inhibitors
    Sahni, Jennifer M.
    Gayle, Sylvia S.
    Webb, Bryan M.
    Weber-Bonk, Kristen L.
    Seachrist, Darcie D.
    Singh, Salendra
    Sizemore, Steven T.
    Restrepo, Nicole A.
    Bebek, Gurkan
    Scacheri, Peter C.
    Varadan, Vinay
    Summers, Matthew K.
    Keri, Ruth A.
    CANCER RESEARCH, 2017, 77 (19) : 5395 - 5408
  • [3] LIN9 is a mitotic vulnerability in triple-negative breast cancer that is targetable with BET inhibitors.
    Sahni, J. M.
    Gayle, S. S.
    Webb, B. M.
    Weber-Bonk, K. L.
    Singh, S.
    Sizemore, S. T.
    Bebek, G.
    Varadan, V.
    Summers, M. K.
    Keri, R. A.
    MOLECULAR BIOLOGY OF THE CELL, 2017, 28
  • [4] LIN9 confers paclitaxel resistance in triple negative breast cancer cells by upregulating CCSAP
    Hongna Lai
    Rui Wang
    Shunying Li
    Qianfeng Shi
    Zijie Cai
    Yudong Li
    Yujie Liu
    Science China Life Sciences, 2020, 63 : 419 - 428
  • [5] LIN9 confers paclitaxel resistance in triple negative breast cancer cells by upregulating CCSAP
    Lai, Hongna
    Wang, Rui
    Li, Shunying
    Shi, Qianfeng
    Cai, Zijie
    Li, Yudong
    Liu, Yujie
    SCIENCE CHINA-LIFE SCIENCES, 2020, 63 (03) : 419 - 428
  • [6] LIN9 confers paclitaxel resistance in triple negative breast cancer cells by upregulating CCSAP
    Hongna Lai
    Rui Wang
    Shunying Li
    Qianfeng Shi
    Zijie Cai
    Yudong Li
    Yujie Liu
    Science China(Life Sciences), 2020, 63 (03) : 419 - 428
  • [7] LIN9 confers paclitaxel resistance in triple negative breast cancer cells by upregulating CCSAP
    Hongna Lai
    Rui Wang
    Shunying Li
    Qianfeng Shi
    Zijie Cai
    Yudong Li
    Yujie Liu
    Science China(Life Sciences), 2020, (03) : 419 - 428
  • [8] LIN9 and NEK2 Are Core Regulators of Mitotic Fidelity That Can Be Therapeutically Targeted to Overcome Taxane Resistance
    Roberts, Melyssa S.
    Sahni, Jennifer M.
    Schrock, Morgan S.
    Piemonte, Katrina M.
    Weber-Bonk, Kristen L.
    Seachrist, Darcie D.
    Avril, Stefanie
    Anstine, Lindsey J.
    Singh, Salendra
    Sizemore, Steven T.
    Varadan, Vinay
    Summers, Matthew K.
    Keri, Ruth A.
    CANCER RESEARCH, 2020, 80 (08) : 1693 - 1706
  • [9] Nek2 is a promising target for triple negative breast cancer treatment strategies
    Lee, Jaehyung
    Gollahon, Lauren
    CANCER RESEARCH, 2011, 71
  • [10] The Nek2 centrosome-mitotic kinase contributes to the mesenchymal state, cell invasion, and migration of triple-negative breast cancer cells
    Yainyrette Rivera-Rivera
    Mihaela Marina
    Shirley Jusino
    Miyoung Lee
    Jaleisha Vélez Velázquez
    Camille Chardón-Colón
    Geraldine Vargas
    Jaya Padmanabhan
    Srikumar P. Chellappan
    Harold I. Saavedra
    Scientific Reports, 11
12345